| Ms Jo-ann Elizabeth Newcomb, RN | |
|
12 Hemlock Rd, Andover, MA 01810 | |
| (978) 470-0631 | |
| Not Available |
| Full Name | Ms Jo-ann Elizabeth Newcomb |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 12 Hemlock Rd, Andover, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235689860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN147871 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jo-ann Elizabeth Newcomb, RN 12 Hemlock Rd, Andover, MA 01810 Ph: (978) 470-0631 | Ms Jo-ann Elizabeth Newcomb, RN 12 Hemlock Rd, Andover, MA 01810 Ph: (978) 470-0631 |
News Archive
AB SCIEX, a global leader in life science analytical technologies, today announced its expansion of commercial operations in Brazil to support the Brazilian scientific community's increasing use of mass spectrometry for food safety testing, environmental analysis, academic research, drug development, forensic toxicology and clinical research.
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test, according to a study between the Department of Physics and Astronomy and the Institute for Biomedical Sciences at Georgia State University.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.
› Verified 9 days ago
Mary Anyzeski, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 349 N Main St, Andover, MA 01810 Phone: 978-475-0959 | |
Daniella G Andujar, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 251 S Main St, Andover, MA 01810 Phone: 978-475-4503 | |
Vivian Jane Burton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 32 Osgood St, Andover, MA 01810 Phone: 978-475-3806 | |
Mrs. Alice Baljian, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 251 S Main St, Andover, MA 01810 Phone: 978-475-4503 | |
Sarah Grace Yanulis, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 323 Lowell St Ste 302, Andover, MA 01810 Phone: 978-475-2731 | |
Gail Hairston, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 39 Rattlesnake Hill Rd, Andover, MA 01810 Phone: 978-806-6677 | |
Andrea Bernier, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 32 Osgood St, Andover, MA 01810 Phone: 978-475-3806 |